Acknowledgments Authors would also like to thank Damla Erbil, ari Demirel, Mehmet Utku Kker, Roza Surme Mizrak, and Ozge Bugdaycigil, who helped for some steps in literature search and data extraction
While most prominent in the US, they have now reached Europe
Pubmed Data : Food Nutr Res
While they address different issues, improving your hormonal balance with spironolactone and your metabolic health with a GLP-1 can lead to better overall health outcomes
Epigenetic differences arise during the lifetime of monozygotic twins
Retatrutide * Triple agonist: GLP-1 + GIP + Glucagon * Pushing biology harder * ~2528% weight loss in trials * Once weekly injection This is efficacy chasing bariatric territory Orforglipron * Oral, non-peptide GLP-1 * No injection, no cold chain drama * Strong A1C + weight data vs oral sema This is scalability at massive level In one line: Retatrutide stretches the ceiling